Member Info for mazik

Not surprised there is only 146 million shares and 50% with instituitional holders, once this settles this will move north..IMO MM know that the SP has legs will do everything to shake weak holders ..The details of RNS does point it will be rerated with contracts in the pipeline "business agreement with the owners of LSN, AI Metrics, LLC, which granted IB global rights to manufacture, market, and distribute the LSN software platform. Now that the FDA has granted market clearance, IB and AI Metrics will begin to actively market and sell LSN in the USA. CE mark for European distribution and commercialisation is expected later this quarter."

MMs played with investors nothing to buy at21 p yesterday at 3pm, lucky I sold my holding only to find that they brought the SP back to 14.5p, truly shocking, lucky I bought back my holding now at 17.5.....Manipulation that they fleeced many..well I hope this goes multiples without panic

jollygoodya,
Watching for few days to topup and will avoid over trading, as CE news and marketing news will keep the sp move up to its realistic value though slowly.

This a good share to keep in the ISA. two days it looked like sky was the limit, when US market opens there seem to be adverse effect to our gains..IMO

1.5 Billion flotation in 2019, how can anyone crash it to £36 million. Richmond group or present Bods " come on u can do better".

Great for some who are enjoying the ride , sorry for turnips like Saunders who are late for the party, market Cap 50 Million 35p/40p

Learnt rebought, 4 times since yesterday, that it has reached but it keeps going up and up, feel market cap should be more like £50 million IMO

Its SNG type of rerating from 5p to over 170p, though this looks like rerating faster due to its product and FDA appoval "Business agreement with the owners of LSN, AI Metrics, LLC, which granted IB global rights to manufacture, market, and distribute the LSN software platform. Now that the FDA has granted market clearance, IB and AI Metrics will begin to actively market and sell LSN in the USA. CE mark for European distribution and commercialisation is expected later this quarter. Well select your value now market cap of £100 million IMO

jollygoodya,
Crossed resistance of 20p, and we are not even midday, US to open around 3pm,,prediction again thrown outside..lol! 30p

Its run by Supply and demand and no logic can be applied just like others...it s moving up towards 30p..IMO

Market cap of £100 million will look cheap, A single liver biopsy can cost between $2,000 and $3,000 per test and is associated with a risk of bleeding. Biopsy sampling is also prone to errors which may result in misdiagnosis.

Goldsmith ,
Agree with you, market cap £25 m should double to reach decent valuation..imo A single liver biopsy can cost between $2,000 and $3,000 per test and is associated with a risk of bleeding. Biopsy sampling is also prone to errors which may result in misdiagnosis.

I have treated mysellf 75k shares, well i will take 21p per share if offered

Going up again, looks like cosolidated just like yesterday had to buy back by paying 50% more...

I concur, on all aspects this seems to be rerated by constant demand..IMO

All logic has been thrown out of the window, cannot complain but have to be part of it ...50p

Drax ...lol! i almost sold bought back for reward for 40p/50

On rollout next month 50p is possible IMO

Missed NCYT and all thers like GDR and ODX....Will this follow suit?

Market Cap £50m on the product within Uk, Global Market anybody's guess